151 related articles for article (PubMed ID: 20931434)
21. Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation.
Sever AZ; Sever M; Vidovic T; Lojo N; Kolenc D; Vuletic LB; Drmic D; Kokot A; Zoricic I; Coric M; Vlainic J; Poljak L; Seiwerth S; Sikiric P
Eur J Pharmacol; 2019 Mar; 847():130-142. PubMed ID: 30690000
[TBL] [Abstract][Full Text] [Related]
22. [Prolonged angiotensin-(1-7) infusion inhibits hepatic fibrosis in rats with bile duct ligation].
Li X; Ning Z; Luo W; Zhang W; Yu C
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):944-7. PubMed ID: 22820573
[TBL] [Abstract][Full Text] [Related]
23. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism.
Peterson TC; Neumeister M
Immunopharmacology; 1996 Mar; 31(2-3):183-93. PubMed ID: 8861744
[TBL] [Abstract][Full Text] [Related]
24. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats.
Gedik N; Kabasakal L; Sehirli O; Ercan F; Sirvanci S; Keyer-Uysal M; Sener G
Life Sci; 2005 Apr; 76(22):2593-606. PubMed ID: 15769483
[TBL] [Abstract][Full Text] [Related]
25. Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats.
Aktas C; Kanter M; Erboga M; Mete R; Oran M
Toxicol Ind Health; 2014 Oct; 30(9):835-44. PubMed ID: 23095487
[TBL] [Abstract][Full Text] [Related]
26. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
Abdel Kawy HS
Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386
[TBL] [Abstract][Full Text] [Related]
27. Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation.
Purucker E; Winograd R; Roeb E; Matern S
Res Exp Med (Berl); 1998 Dec; 198(4):167-74. PubMed ID: 9879595
[TBL] [Abstract][Full Text] [Related]
28. Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation.
Ale-Ebrahim M; Eidi A; Mortazavi P; Tavangar SM; Tehrani DM
J Trace Elem Med Biol; 2015 Jan; 29():242-8. PubMed ID: 25084733
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of resveratrol against oxidative stress in cholestasis.
Ara C; Kirimlioglu H; Karabulut AB; Coban S; Ay S; Harputluoglu M; Kirimlioglu V; Yilmaz S
J Surg Res; 2005 Aug; 127(2):112-7. PubMed ID: 16083749
[TBL] [Abstract][Full Text] [Related]
30. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
31. Lanreotide on collateral response to endothelin-1 and vasopressin in cirrhotic rats.
Huang HC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Yang YY; Lee SD
J Chin Med Assoc; 2006 Sep; 69(9):397-403. PubMed ID: 17051749
[TBL] [Abstract][Full Text] [Related]
32. The effects of hyperbaric oxygen application against cholestatic oxidative stress and hepatic damage after bile duct ligation in rats.
Ayvaz S; Kanter M; Aksu B; Sahin SH; Uzun H; Erboga M; Pul M
J Surg Res; 2013 Jul; 183(1):146-55. PubMed ID: 23462455
[TBL] [Abstract][Full Text] [Related]
33. Spotlight on lanreotide Autogel in acromegaly.
Croxtall JD; Scott LJ
BioDrugs; 2008; 22(4):275-7. PubMed ID: 18611070
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
35. PPAR-alpha agonist treatment increases trefoil factor family-3 expression and attenuates apoptosis in the liver tissue of bile duct-ligated rats.
Karakan T; Kerem M; Cindoruk M; Engin D; Alper M; Akın O
Turk J Gastroenterol; 2013; 24(2):134-40. PubMed ID: 23934460
[TBL] [Abstract][Full Text] [Related]
36. L-carnitine ameliorates bile duct ligation induced liver fibrosis via reducing the nitrosative stress in experimental animals: preclinical evidences.
Nimbalkar V; Vyawahare N
Heliyon; 2021 Nov; 7(11):e08488. PubMed ID: 34901512
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation.
Mayoral P; Criado M; Hidalgo F; Flores O; Arévalo MA; Eleno N; Sánchez-Rodríguez A; López-Novoa JM; Esteller A
Clin Sci (Lond); 1999 Mar; 96(3):297-305. PubMed ID: 10029566
[TBL] [Abstract][Full Text] [Related]
38. Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.
Tarçin O; Gedik N; Karakoyun B; Tahan V; Sood G; Celikel C; Tözün N
Dig Dis Sci; 2008 Jul; 53(7):1938-45. PubMed ID: 17999185
[TBL] [Abstract][Full Text] [Related]
39. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
40. Hepatotoxicity effect of short-term Bradykinin potentiating factor in cholestatic rats.
Fahmy SR; Mohamed AS; Hosney M; Issa HA; Hassanein SS; Soliman AM
Toxicol Lett; 2019 Feb; 301():73-78. PubMed ID: 30458228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
